While no therapies targeting IL-6 pathway inhibitors in individuals with osteoarthritis have been developed, the antibody tocilizumab is an effective treatment in certain conditions when IL-6 levels are increased [42]. The gene discussed is IL6; the disease is osteoarthritis.